Haddad Iman I - OmicsDI

Show results for

Unknown (4)
Proteomics (2)

Organisms

Alphavirus (2)
Anemia (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Chlamydomonas reinhardtii (2)
Chlorella vulgaris (2)
Clostridium perfringens (2)
Dengue virus (2)
Eukaryota (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Kamptonema sp. (2)
Listeria monocytogenes (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Pseudomonas aeruginosa (2)
Rattus (2)
Sarbecovirus (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Staphylococcus aureus (2)
Streptococcus pneumoniae (2)
Viruses (2)

Repository

pride (2)

Tissue

Cell culture (2)
Epithelial cell (2)

Technology Type

Bottom-up proteomics (2)
Data-dependent acquisition (2)
Mass Spectrometry (2)

Publication Date

2026 (2)

Release Date

2023 (2)
2025 (1)
2022 (1)

Lab affiliation

ESPCI Paris, Université PSL, UAR2051 CNRS, 75005, Paris, France (2)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Study partners of NHS protein by proteomics

I am studying the NHS, the founding member of the NHS protein family, following the work of Yanan Wang, that discovered the WAVE shell complex, containing NHSL1 instead of WAVE (https://doi.org/10.1038/s41467-023-39276-w) Our recent experiments of the single cell migration show that NHS KO cells hav...

ORGANISM(S): Homo sapiens (Human)

2026-09-21 | PXD070850 | Pride

Study partners of ABI1 protein by proteomics

We are analyzing the WAVE complex in NHS KO vs. parental MCF10A cells by performing TAP of FLAG-GFP ABI1, a WAVE complex subunit. This follows our sucrose gradient analysis, where we observed a slight shift of the WAVE complex towards heavier fractions in NHS KO cells, indicating potential additio...

ORGANISM(S): Homo sapiens (Human)

2026-09-21 | PXD070942 | Pride

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC10957483 | biostudies-literature

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC11872607 | biostudies-literature

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.

Not available

S-EPMC9333998 | biostudies-literature

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.